DOCSLIB.ORG

Communicable and Environmental Diseases and Emergency Preparedness

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Communicable and Environmental Diseases and Emergency Preparedness Communicable and Environmental Diseases and Emergency Preparedness 2010-2012 Annual Report Communicable and Environmental Disease Services Tennessee Department of Health 1st Floor, Cordell Hull Building 425 5th Avenue North Nashville, Tennessee 37243 Phone 615-741-7247 (24 hours a day/7 days a week) Toll-Free 800-404-3006 Fax 615-741-3857 Communicable and Environmental Diseases and Emergency Preparedness Annual Report Tennessee Department of Health Communicable and Environmental Diseases and Emergency Preparedness John Dreyzehner, MD, MPH, FACOEM, Commissioner of Health David Reagan, MD, PhD, Chief Medical Officer Timothy F. Jones, MD, State Epidemiologist, Director, Communicable and Environmental Diseases and Emergency Preparedness Available electronically at the Tennessee Department of Health website. In the search box in the top right-hand corner, type “CEDEP Annual Report” and hit Enter. Under Search Results, click on the result entitled “CEDEP Reports”. http://www.tn.gov/health This report reflects the contributions of the many committed professionals who are part of the Communicable and Environmental Disease Services Section, Tennessee Department of Health. iii Communicable and Environmental Diseases and Emergency Preparedness Annual Report TABLE OF CONTENTS Section I. Introduction ...................................................................................................................................................... 1 A. Purpose of Report ...................................................................................................................................... 2 B. Notifiable Diseases in Tennessee .............................................................................................................. 2 C. Reporting Notifiable Diseases ................................................................................................................... 3 D. List of Notifiable Diseases ......................................................................................................................... 4 E. Isolate Characterization at the State Laboratory ...................................................................................... 6 F. Referral of Cultures or Positive Specimens to the Department of Health .............................................. 6 G. Tennessee Department of Health Regions ............................................................................................... 7 H. Useful Contact Persons, Telephone Numbers, E-Mail and U.S. Addresses ........................................... 7 I. Emerging Infections and the Emerging Infections Program .................................................................... 8 J. Communicable and Environmental Disease and Emergency Preparedness Website ............................. 9 K. Tennessee Population Estimates, 2012................................................................................................... 10 L. Tennessee’s Department of Health Regions: Counties and Population, 2012 ..................................... 10 M. Notes on Sources Used in Preparing the Annual Report ...................................................................... 12 Section II. Tennessee Reported Cases, 2003-2012 .......................................................................................................... 14 Reported Cases, by Year of Diagnosis, Tennessee, 2003-2012....................................................................... 15 Numbers of Reported Cases of Selected Notifiable Diseases with Rates per 100,000 Persons, by Age Group, Tennessee, 2012 ...................................................................................................................... 16 Section III. Disease Summaries .......................................................................................................................................... 18 A. Foodborne and Waterborne Diseases ..................................................................................................... 19 Tennessee FoodNet and FoodCORE Programs..................................................................................... 20 Campylobacteriosis ......................................................................................................................... 21 Listeriosis ......................................................................................................................................... 23 Salmonellosis ................................................................................................................................... 23 Shiga-toxin Producing E. coli and Hemolytic Uremic Syndrome .................................................. 25 Shigellosis ........................................................................................................................................ 26 Vibriosis and Cholera ..................................................................................................................... 27 Yersiniosis ........................................................................................................................................ 28 Foodborne and Waterborne Parasitic Diseases ...................................................................................... 28 Cryptosporidiosis ............................................................................................................................ 29 Cyclosporiasis .................................................................................................................................. 30 Foodborne Outbreaks ..................................................................................................................... 31 v Communicable and Environmental Diseases and Emergency Preparedness Annual Report TABLE OF CONTENTS (CONTINUED) B. Invasive Diseases ...................................................................................................................................... 33 Active Bacterial Core Surveillance (ABCs) ............................................................................................. 34 Other EIP Surveillance Activities ............................................................................................................ 35 Invasive Group A Streptococcal Disease ................................................................................................ 35 Invasive Group B Streptococcal Disease ................................................................................................. 37 Meningococcal Disease ............................................................................................................................ 38 Methicillin Resistant Staphylococcus aureus Invasive Disease—Passive Surveillance ................................ 39 Streptococcus pneumoniae Invasive Disease ................................................................................................ 40 C. Hepatitis ................................................................................................................................................... 43 Hepatitis A ............................................................................................................................................... 44 Perinatal Hepatitis B ................................................................................................................................ 45 Acute Hepatitis B Virus Infection .......................................................................................................... 45 Hepatitis C Virus ..................................................................................................................................... 47 D. Vaccine-Preventable Diseases .................................................................................................................. 49 Pertussis .................................................................................................................................................... 51 Tetanus ..................................................................................................................................................... 52 Influenza .................................................................................................................................................. 53 E. Vectorborne and Zoonotic Diseases ...................................................................................................... 55 Arboviral Diseases .................................................................................................................................... 56 LaCrosse Encephalitis (LAC) ........................................................................................................ 56 West Nile Fever/Encephalitis ......................................................................................................... 57 Malaria ............................................................................................................................................. 58 Tickborne Diseases ................................................................................................................................ 59 Ehrlichiosis ...................................................................................................................................... 59 Lyme Disease ..................................................................................................................................
Load more

Recommended publications
  • Bacterial Skin Infections an Observational Study
    RESEARCH Geoffrey Spurling Deborah Askew David King Geoffrey K Mitchell MBBS, DTM&H, FRACGP, is Senior PhD, is Senior Research Fellow, MBBS, MPH, FRACGP, is Senior Lecturer, MBBS, PhD, FRACGP, FAChPM, Lecturer, Discipline of General Practice, Discipline of General Practice, Discipline of General Practice, University is Associate Professor, Discipline University of Queensland. g.spurling@ University of Queensland. of Queensland. of General Practice, University of uq.edu.au Queensland. Bacterial skin infections An observational study Bacterial skin infections such as impetigo and boils are Background common, contagious, often painful, and have the potential to We aimed to determine the feasibility of measuring resolution rates of recur. They are caused by Staphylococcus aureus and bacterial skin infections in general practice. occasionally by Streptococcus pyogenes, and are transmitted Methods by skin-to-skin contact, fomite contact or contact with nasal Fifteen general practitioners recruited patients from March 2005 to carriers.1 In the United Kingdom, incidence of skin infections October 2007 and collected clinical and sociodemographic data at in children in 2005 was approximately 75 per 100 000.2 Skin baseline. Patients were followed up at 2 and 6 weeks to assess lesion infection rates are likely to be higher in warmer climates. The resolution. only Australian data we found were for one Northern Territory Results Aboriginal Medical Service (Danila Dilba), which recorded 7.5 Of 93 recruited participants, 60 (65%) were followed up at 2 and 6 per 100 consultations for localised skin infections.3 weeks: 50% (30) had boils, 37% (22) had impetigo, 83% (50) were prescribed antibiotics, and active follow up was suggested for 47% Suggested risk factors for impetigo include: household crowding, (28).
    [Show full text]
  • HISTORY of LEAD POISONING in the WORLD Dr. Herbert L. Needleman Introduction the Center for Disease Control Classified the Cause
    HISTORY OF LEAD POISONING IN THE WORLD Dr. Herbert L. Needleman Introduction The Center for Disease Control classified the causes of disease and death as follows: 50 % due to unhealthy life styles 25 % due to environment 25% due to innate biology and 25% due to inadequate health care. Lead poisoning is an environmental disease, but it is also a disease of life style. Lead is one of the best-studied toxic substances, and as a result we know more about the adverse health effects of lead than virtually any other chemical. The health problems caused by lead have been well documented over a wide range of exposures on every continent. The advancements in technology have made it possible to research lead exposure down to very low levels approaching the limits of detection. We clearly know how it gets into the body and the harm it causes once it is ingested, and most importantly, how to prevent it! Using advanced technology, we can trace the evolution of lead into our environment and discover the health damage resulting from its exposure. Early History Lead is a normal constituent of the earth’s crust, with trace amounts found naturally in soil, plants, and water. If left undisturbed, lead is practically immobile. However, once mined and transformed into man-made products, which are dispersed throughout the environment, lead becomes highly toxic. Solely as a result of man’s actions, lead has become the most widely scattered toxic metal in the world. Unfortunately for people, lead has a long environmental persistence and never looses its toxic potential, if ingested.
    [Show full text]
  • Inflammatory Or Infectious Hair Disease? a Case of Scalp Eschar and Neck Lymph Adenopathy After a Tick Bite
    Case Report ISSN: 2574 -1241 DOI: 10.26717/BJSTR.2021.35.005688 Adherent Serous Crust of the Scalp: Inflammatory or Infectious Hair Disease? A Case of Scalp Eschar and Neck Lymph Adenopathy after a Tick Bite Starace M1, Vezzoni R*2, Alessandrini A1 and Piraccini BM1 1Dermatology - IRCCS, Policlinico Sant’Orsola, Department of Specialized, Experimental and Diagnostic Medicine, Alma Mater Studiorum, University of Bologna, Italy 2Dermatology Clinic, Maggiore Hospital, University of Trieste, Italy *Corresponding author: Roberta Vezzoni, Dermatology Clinic, Maggiore Hospital, University of Trieste, Italy ARTICLE INFO ABSTRACT Received: Published: April 17, 2021 The appearance of a crust initially suggests inflammatory scalp diseases, although infectious diseases such as impetigo or insect bites should also be considered among April 27, 2021 the differential diagnoses. We report a case of 40-year-old woman presentedB. Burgdorferi to our, Citation: Starace M, Vezzoni R, Hair Disease Outpatient Service with an adherent serous crust on the scalp and lymphadenopathy of the neck. Serological tests confirmed the aetiology of while rickettsia infection was excluded. Lyme borreliosis can mimic rickettsia infection Alessandrini A, Piraccini BM. Adherent and may present as scalp eschar and neck lymphadenopathy after a tick bite (SENLAT). Serous Crust of the Scalp: Inflammatory Appropriate tests should be included in the diagnostic workup of patients with necrotic or Infectious Hair Disease? A Case of Scalp scalpKeywords: eschar in order to promptly set
    [Show full text]
  • Bacterial Infections Diseases Picture Cause Basic Lesion
    page: 117 Chapter 6: alphabetical Bacterial infections diseases picture cause basic lesion search contents print last screen viewed back next Bacterial infections diseases Impetigo page: 118 6.1 Impetigo alphabetical Bullous impetigo Bullae with cloudy contents, often surrounded by an erythematous halo. These bullae rupture easily picture and are rapidly replaced by extensive crusty patches. Bullous impetigo is classically caused by Staphylococcus aureus. cause basic lesion Basic Lesions: Bullae; Crusts Causes: Infection search contents print last screen viewed back next Bacterial infections diseases Impetigo page: 119 alphabetical Non-bullous impetigo Erythematous patches covered by a yellowish crust. Lesions are most frequently around the mouth. picture Lesions around the nose are very characteristic and require prolonged treatment. ß-Haemolytic streptococcus is cause most frequently found in this type of impetigo. basic lesion Basic Lesions: Erythematous Macule; Crusts Causes: Infection search contents print last screen viewed back next Bacterial infections diseases Ecthyma page: 120 6.2 Ecthyma alphabetical Slow and gradually deepening ulceration surmounted by a thick crust. The usual site of ecthyma are the legs. After healing there is a permanent scar. The pathogen is picture often a streptococcus. Ecthyma is very common in tropical countries. cause basic lesion Basic Lesions: Crusts; Ulcers Causes: Infection search contents print last screen viewed back next Bacterial infections diseases Folliculitis page: 121 6.3 Folliculitis
    [Show full text]
  • Environmental Health Playbook: Investing in a Robust Environmental Health System Executive Summary
    Environmental Health Playbook: Investing in a Robust Environmental Health System Executive Summary Background and Need for Action Environmental Health is the branch of public health that focuses on the interrelationships between people and their environment, promotes human health and well-being, and fosters healthy and safe communities. As a fundamental component of a comprehensive public health system, environmental health works to advance policies and programs to reduce chemical and other environmental exposures in air, water, soil, and food to protect residents and provide communities with healthier environments. Environmental health protects the public by tracking environmental exposures in communities across the United States and potential links with disease outcomes. To achieve a healthy community, homes should be safe, affordable, and healthy places for families to gather. Workplaces, schools, and child care centers should be free of exposures that negatively impact the health of workers or children. Nutritious, affordable foods should be safe for all community members. Access to safe and affordable multimodal transportation options, including biking and public transit, improves the environment and drives down obesity and other chronic illnesses. Outdoor and indoor air quality in all communities should be healthy and safe to breathe for everyone. Children and adults alike should have access to safe and clean public spaces, such as parks. When a disaster strikes, a community needs to be prepared; it should have the tools and resources to be resilient against physical (infrastructure and human) and emotional damage. All these activities require the participation of federal, state, local, and tribal governments. Building a Robust Environmental Health System Investing in essential governmental environmental health services through dedicated resources will create an effective environmental health system that proactively protects communities and helps everyone attain good health.
    [Show full text]
  • Animal Biosafety Level
    Biological Safety Manual Prepared by: Environmental Health and Safety Office April 2012 Table of Contents Table of Contents .................................................................................................................... ii Tables and Figures ................................................................................................................. vii Acronyms ........................................................................................................................... viii Foreword ............................................................................................................................... x Document History .................................................................................................................... x 1.0 Introduction ........................................................................................................ 1-1 1.1 Biological Material ............................................................................................. 1-1 1.1.1 Biohazardous Material ........................................................................................ 1-1 1.1.2 Nonbiohazardous Material .................................................................................. 1-2 1.2 Regulations, Guidelines, and Permit Requirements ............................................. 1-2 1.3 Roles and Responsibilities ................................................................................... 1-4 1.3.1 Vice President for Research and Economic Development
    [Show full text]
  • 022291S015 Eltrombopag Clinical BPCA
    CLINICAL REVIEW Application Type sNDA Application Number(s) 022291, S-015 Priority or Standard Priority Submit Date(s) December 19, 2014 Received Date(s) December 19, 2014 PDUFA Goal Date June 19, 2015 Division / Office Division of Hematology Products/OHOP Reviewer Name(s) Lori A. Ehrlich Review Completion Date May 26, 2015 Established Name Eltrombopag Trade Name Promacta® Therapeutic Class Thrombopoietin Agonist Applicant Glaxo SmithKline Formulation(s) Tablet Dosing Regimen 50 mg once daily Indication(s) Chronic ITP Intended Population(s) Pediatric patients ≥6 years old with chronic ITP Template Version: March 6, 2009 Reference ID: 3765521 Clinical Review Lori A. Ehrlich, MD, PhD NDA 022291, S-015 Promacta® (eltrombopag) tablets Table of Contents 1 RECOMMENDATIONS/RISK BENEFIT ASSESSMENT ......................................... 8 1.1 Recommendation on Regulatory Action ............................................................. 8 1.2 Risk Benefit Assessment.................................................................................... 9 1.3 Recommendations for Postmarket Risk Evaluation and Mitigation Strategies . 11 1.4 Recommendations for Postmarket Requirements and Commitments .............. 11 2 INTRODUCTION AND REGULATORY BACKGROUND ...................................... 11 2.1 Product Information .......................................................................................... 12 2.2 Tables of Currently Available Treatments for Proposed Indications ................. 12 2.3 Availability of Proposed Active Ingredient
    [Show full text]
  • Advancing Healthy Housing: a Strategy for Action Abbreviations
    healthyhomes.hud.gov Advancing Healthy Housing A STRATEGY FOR ACTION 2013 A Report from the Federal Healthy Homes Work Group Table of Contents Abbreviations __________________________________________________________________3 Executive Summary ________________________________________________________________4 Introduction __________________________________________________________________8 Advancing Healthy Housing Goals ___________________________________________________16 Goal 1 Establish Healthy Homes Recommendations _________________________________17 1.1 Establish Recommendations for Assessing Health and Safety Hazards ______17 Goal 2 Encourage Adoption of Healthy Homes Recommendations _____________________19 2.1 Obtain Commitments from Agencies to Advance Healthy Housing ________19 2.2 Strengthen Federal Efforts to Reduce Public Health Risks in Housing _______20 2.3 Explore Ways to Leverage Funding across Federal and Non-Federal Programs _______________________________________________21 Goal 3 Create and Support Training and Workforce Development to Address Health Hazards in Housing ______________________________________________________22 3.1 Support Enhanced Healthy Homes Training and Workforce Development __22 3.2 Accelerate Replication of Successful Local Healthy Housing Programs ______23 3.3 Encourage Pilots or Demonstration Programs that Advance Healthy Housing ____________________________________________23 Goal 4 Educate the Public about Healthy Homes ____________________________________24 4.1 Develop a Communications Strategy
    [Show full text]
  • Environmental Threats to Children's Health in Southeast Asia and The
    Children’s Health Review Environmental Threats to Children’s Health in Southeast Asia and the Western Pacific William A. Suk,1 Kuhnying Mathuros Ruchirawat,2 Kalpana Balakrishnan,3 Martha Berger,4 David Carpenter,5 Terri Damstra,6 Jenny Pronczuk de Garbino,7 David Koh,8 Philip J. Landrigan,9 Irma Makalinao,10 Peter D. Sly,11 Y. Xu,12 and B.S. Zheng13 1Center for Risk and Integrated Sciences, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA; 2Chulabhorn Research Institute, Bangkok, Thailand; 3Sri Ramachandra Medical College and Research Institute, Porur, Chennai, India; 4Office of Children’s Health Protection, U.S. Environmental Protection Agency, Washington, DC, USA; 5School of Public Health, University at Albany, Rensselaer, New York, USA; 6World Health Organization, International Programme on Chemical Safety, Research Triangle Park, North Carolina, USA; 7World Health Organization, International Programme on Chemical Safety, Geneva, Switzerland; 8National University of Singapore, Department of Community, Occupational and Family Medicine, Singapore; 9Center for Children’s Health and the Environment, Department of Community and Preventive Medicine, Mount Sinai School of Medicine, New York, New York, USA; 10Department of Pharmacology and Toxicology, University of the Philippines College of Medicine, Manila, Philippines; 11Princess Margaret Hospital for Children, Child Health Research, Subiaco, Washington, USA; 12Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan, People’s Republic of China; 13Institute of Geochemistry, Chinese Academy of Sciences, Guiyang, People’s Republic of China chemicals. In recognition of these new threats, The Southeast Asia and Western Pacific regions contain half of the world’s children and are among the evaluation and management of risk to the most rapidly industrializing regions of the globe.
    [Show full text]
  • Skin Disease and Disorders
    Sports Dermatology Robert Kiningham, MD, FACSM Department of Family Medicine University of Michigan Health System Disclosures/Conflicts of Interest ◼ None Goals and Objectives ◼ Review skin infections common in athletes ◼ Establish a logical treatment approach to skin infections ◼ Discuss ways to decrease the risk of athlete’s acquiring and spreading skin infections ◼ Discuss disqualification and return-to-play criteria for athletes with skin infections ◼ Recognize and treat non-infectious skin conditions in athletes Skin Infections in Athletes ◼ Bacterial ◼ Herpetic ◼ Fungal Skin Infections in Athletes ◼ Very common – most common cause of practice-loss time in wrestlers ◼ Athletes are susceptible because: – Prone to skin breakdown (abrasions, cuts) – Warm, moist environment – Close contacts Cases 1 -3 ◼ 21 year old male football player with 4 day h/o left axillary pain and tenderness. Two days ago he noticed a tender “bump” that is getting bigger and more tender. ◼ 16 year old football player with 3 day h/o mildly tender lesions on chin. Started as a single lesion, but now has “spread”. Over the past day the lesions have developed a dark yellowish crust. ◼ 19 year old wrestler with a 3 day h/o lesions on right side of face. Noticed “tingling” 4 days ago, small fluid filled lesions then appeared that have now started to crust over. Skin Infections Bacterial Skin Infections ◼ Cellulitis ◼ Erysipelas ◼ Impetigo ◼ Furunculosis ◼ Folliculitis ◼ Paronychea Cellulitis Cellulitis ◼ Diffuse infection of connective tissue with severe inflammation of dermal and subcutaneous layers of the skin – Triad of erythema, edema, and warmth in the absence of underlying foci ◼ S. aureus or S. pyogenes Erysipelas Erysipelas ◼ Superficial infection of the dermis ◼ Distinguished from cellulitis by the intracutaneous edema that produces palpable margins of the skin.
    [Show full text]
  • EXECUTIVE SUMMARY WHO Library Cataloguing-In-Publication Data
    PREVENTING DISEASE THROUGH HEALTHY ENVIRONMENTS Towards an estimate of the environmental burden of disease EXECUTIVE SUMMARY WHO Library Cataloguing-in-Publication Data Prüss-Üstün, Annette. Preventing disease through healthy environments : towards an estimate of the environmental burden of disease : executive summary / Prüss-Üstün A, Corvalán C. 1.Environmental monitoring. 2.Cost of illness. 3.Risk factors. I.Corvalán, Carlos F. II.World Health Organization. III.Title. ISBN 92 4 159420 9 (NLM classification: WA 30.5) ISBN 978 92 4 159420 2 © World Health Organization 2006 All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; e-mail: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned.
    [Show full text]
  • Factsheet Boils and Impetigo
    FACTSHEET BOILS AND IMPETIGO WHAT IS A BOIL? HOW CAN YOU STOP THE SPREAD OF BOILS A boil is an infection of the skin, usually caused by AND IMPETIGO? Staphylococcus bacteria. Boils are tender, swollen sores, Wash your hands which are full of pus. The tenderness usually goes away, Hand washing is the most important way to prevent the once the boil bursts and the pus and fluid drain. spread of boils and impetigo. Wash all parts of your hands (including between the fingers and under fingernails) WHAT IS IMPETIGO? vigorously with soap and running water for 10-15 seconds. Impetigo is an infection of the skin caused by either Rinse well and dry your hands (with a paper towel if you Staphylococcus or Streptococcus bacteria. The symptoms can). Wash your hands: of impetigo are either small blisters or flat, honey-coloured crusty sores, on the skin. Impetigo is sometimes called • before and after touching or dressing an infected area ‘school sores’. or wound; • after going to the toilet; HOW ARE BOILS AND IMPETIGO TREATED? • after blowing your nose; If you have the symptoms of boils or impetigo: • before handling or eating food; • see your doctor for advice on the treatment of both; • before handling newborn babies; • if sores are small or few, local antiseptic cream and hot • after touching or handling unwashed clothing or linen; compresses may help; • after handling animals or animal waste. • your doctor may prescribe you antibiotic tablets or Cover boils and impetigo ointment. It is important to take the full course of antibiotics. If you don’t, the sores may come back.
    [Show full text]